On ECHEMI
Home > Drugs > Urinary tract tumors
Urinary tract tumors
Urethral tumors include male urethral cancer and female urethral cancer. The primary site of male urethral cancer varies, and most common ones are transitional cell carcinoma and squamous cell carcinoma. The cause of the disease is related to urethritis, urethral stenosis and repeated urethral dilatation. However, when the tumor invades the penis and perineum, it can metastasize to the inguinal lymph nodes. Urethral cancer rarely metastasizes through the blood. In the late stage, the most distant sites of metastasis are the lungs, followed by the liver and stomach.
  • Site of disease:

    Kidney ureter bladder
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Dull pain in waist blood in urine weight loss abdominal mass edema
  • Concurrent disease:

Related Drugs
Hydroxyurea tablets
Indication: 1. It is effective for chronic myeloid leukemia (CML) and can be used for CML resistant to Myleranine; 2. It has certain effects on melanoma, renal cancer, head and neck cancer, and is effective in combination with radiotherapy for head and neck and cervical squamous cell carcinoma.
Manufacturer:

Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.

Chloroquine
Indication: Used for the treatment of breast cancer, lung cancer, liver cancer, leukemia, rectal cancer, colon cancer, bladder cancer, gastric cancer, kidney cancer, pancreatic cancer, osteosarcoma, malignant lymphoma, brain tumors, etc.
Manufacturer:

Tonghua Mao Xiang Pharmaceutical Co., Ltd.

Fludarabine phosphate
Indication: For the treatment of patients with B-cell chronic lymphocytic leukemia (CLL) whose disease has not improved or has progressed during or after treatment with at least one standard alkylating agent-containing regimen.
Manufacturer:

Nanjing Hairun Pharmaceutical Co., Ltd.

Fludarabine Phosphate for Injection
Indication: For the treatment of patients with B-cell chronic lymphocytic leukemia (CLL) whose disease has not improved or has progressed during or after treatment with at least one standard alkylating agent-containing regimen.
Tegafur Capsules
Indication: It is mainly used to treat digestive tract tumors, and has certain effects on gastric cancer, colon cancer, and rectal cancer. It can also be used to treat breast cancer, bronchial lung cancer, liver cancer, etc. It can also be used for bladder cancer, prostate cancer, kidney cancer, etc.
Manufacturer:

Chengdu Tongde Pharmaceutical Co., Ltd.

Tegafur Tablets
Indication: It is mainly used to treat digestive tract tumors, and has certain effects on gastric cancer, colon cancer, and rectal cancer. It can also be used to treat breast cancer, bronchial lung cancer, liver cancer, etc. It can also be used for bladder cancer, prostate cancer, kidney cancer, etc.
Pingxiao tablets
Manufacturer:

Chongqing Pharscin Pharmaceutical Co., Ltd.

Medroxyprogesterone acetate capsules
Indication: Used for palliative or adjuvant treatment of inoperable, recurrent or metastatic hormone-dependent tumors, such as endometrial cancer, renal cancer, breast cancer, etc.
Manufacturer:

Nanjing Cuccess Pharmaceutical Co., Ltd.

Fludarabine Phosphate for Injection
Indication: For the treatment of patients with B-cell chronic lymphocytic leukemia (CLL) whose disease has not improved or has progressed during or after treatment with at least one standard alkylating agent-containing regimen.
Manufacturer:

Chongqing Lummy Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.